When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
After reporting favorable pricing for its previously disclosed equity offering, shares in Aurinia Pharmaceuticals(NASDAQ: AUPH) rallied 12.2% on Tuesday.
It's been a busy week for Aurinia's investor relations team. On Dec. 4, the company reported positive phase 3 trial results for voclosporin, combined with Roche's CellCept and low-dose corticosteroids, in lupus nephritis patients. The report sent shares skyrocketing 125%.